MicroPort CardioFlow has announced a strategic merger with MicroPort CRM, bringing MicroPort CRM into the MicroPort CardioFlow family. The combined capabilities of both companies aim to establish a comprehensive platform in structural heart, cardiac rhythm management, and heart failure, with the goal of accelerating access to advanced cardiovascular technologies worldwide.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.